Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1994 1
1995 2
1996 1
1998 2
1999 1
2002 1
2003 1
2004 1
2005 1
2006 1
2008 1
2009 2
2010 2
2011 1
2013 1
2016 1
2017 2
2020 1
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S, Friedrich K, Redline R, Avril S. Hauptmann S, et al. Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27. Virchows Arch. 2017. PMID: 28025670 Free PMC article. Review.
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. ...An important change in the WHO 2014 classification is the new terminology of non-invasive implants a …
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between …
Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors.
Mirzaoglu M, Yavuzkir S, Mirzaoglu C, Yurt N, Dagli AF, Ozcan Yildirim S, Sahin İ, Aydin S. Mirzaoglu M, et al. Biotech Histochem. 2023 Feb;98(2):140-146. doi: 10.1080/10520295.2022.2135763. Epub 2022 Oct 25. Biotech Histochem. 2023. PMID: 36281766
Asprosin (ASP) and subfatin are hormones that regulate glucose metabolism. The role of ASP and subfatin in serous ovarian tumors has not been investigated. We investigated the expression of subfatin and asprosin in 30 serous benign, 30 serous …
Asprosin (ASP) and subfatin are hormones that regulate glucose metabolism. The role of ASP and subfatin in serous ovarian t …
OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN, Lewinger JP, Gooden G, Spillman M, Neuman M, Guo XM, Tew BY, Miller H, Khetan VU, Shulman LP, Roman L, Salhia B. Buckley DN, et al. Clin Cancer Res. 2023 Dec 15;29(24):5196-5206. doi: 10.1158/1078-0432.CCR-23-1197. Clin Cancer Res. 2023. PMID: 37812492 Free PMC article.
PURPOSE: High-grade serous ovarian carcinoma (HGSOC) is the most lethal epithelial ovarian cancer (EOC) and is often diagnosed at late stage. ...RESULTS: OvaPrint achieved a positive predictive value of 95% and a negative predictive value of 88% for discrimin …
PURPOSE: High-grade serous ovarian carcinoma (HGSOC) is the most lethal epithelial ovarian cancer (EOC) and is often di …
Ovarian needle aspiration in the diagnosis and management of ovarian masses.
Nagamine K, Kondo J, Kaneshiro R, Tauchi-Nishi P, Terada K. Nagamine K, et al. J Gynecol Oncol. 2017 Jul;28(4):e40. doi: 10.3802/jgo.2017.28.e40. J Gynecol Oncol. 2017. PMID: 28541632 Free PMC article.
OBJECTIVE: Ovarian needle aspiration and biopsy (ONAB) may be employed for pretreatment diagnosis of ovarian malignancies or intraoperatively to facilitate removal of ovarian masses. ...Ninety-two (64%) cases had corresponding histopathology, 84 (91%) of whic …
OBJECTIVE: Ovarian needle aspiration and biopsy (ONAB) may be employed for pretreatment diagnosis of ovarian malignancies or i …
Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice.
Ohya A, Fujinaga Y. Ohya A, et al. Jpn J Radiol. 2022 Dec;40(12):1213-1234. doi: 10.1007/s11604-022-01321-x. Epub 2022 Aug 2. Jpn J Radiol. 2022. PMID: 35916971 Free PMC article. Review.
However, with the exclusion of rare ovarian tumors, the number of ovarian tumors encountered in daily practice is somewhat fixed. ...First, unilocular cystic masses without mural nodules/solid components include benign lesions such as serous …
However, with the exclusion of rare ovarian tumors, the number of ovarian tumors encountered in daily practice i …
Differential diagnosis of gynecologic organ-related diseases in women presenting with ascites.
Cheng MH, Yen MS, Chao KC, Sheu BC, Wang PH. Cheng MH, et al. Taiwan J Obstet Gynecol. 2008 Dec;47(4):384-90. doi: 10.1016/S1028-4559(09)60003-6. Taiwan J Obstet Gynecol. 2008. PMID: 19126502 Free article. Review.
Ascites is also a common manifestation of some gynecologic diseases. It is important that health care workers consider gynecologic problems among the potential differential diagnoses in patients presenting with ascites. Various kinds of ovarian diseases, such as epi …
Ascites is also a common manifestation of some gynecologic diseases. It is important that health care workers consider gynecologic pr …
CytoSaLPs score: a promising new tool for the detection and screening of extrauterine high grade serous carcinoma.
Lekka S, Psomiadou V, Panoskaltsis T, Tsouma E, Novkovic N, Trihia H, Tzaida O, Korfias D, Giannakas P, Iavazzo C, Vakas P, Vlahos N, Vorgias G. Lekka S, et al. BMC Cancer. 2023 Feb 16;23(1):157. doi: 10.1186/s12885-023-10607-w. BMC Cancer. 2023. PMID: 36797677 Free PMC article.
BACKGROUND: A recent theory supports that high-grade serous epithelial ovarian cancer derives from the fimbrial end of the fallopian tube and during the last decade, a few studies have examined the fallopian tube cytology. Our study aims to determine the cytomorphol …
BACKGROUND: A recent theory supports that high-grade serous epithelial ovarian cancer derives from the fimbrial end of the fal …
SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia.
Chapel DB, Hirsch MS. Chapel DB, et al. Am J Surg Pathol. 2022 Feb 1;46(2):213-219. doi: 10.1097/PAS.0000000000001792. Am J Surg Pathol. 2022. PMID: 34411029
Primary peritoneal malignant mesothelioma (MM) can demonstrate morphologic overlap with low-grade and high-grade tubo-ovarian serous neoplasms; it is also biologically and prognostically distinct from benign mesothelial proliferations. ...Quantitative …
Primary peritoneal malignant mesothelioma (MM) can demonstrate morphologic overlap with low-grade and high-grade tubo-ovarian sero …
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Shappell HW, et al. Am J Surg Pathol. 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. Am J Surg Pathol. 2002. PMID: 12459620 Review.
Ovarian endocervical-type (mullerian) mucinous tumors and tumors composed of a mixture of endocervical-type mucinous, serous, endometrioid, squamous, and indifferent cells with abundant eosinophilic cytoplasm reported to date have been primarily limite …
Ovarian endocervical-type (mullerian) mucinous tumors and tumors composed of a mixture of endocervical-type mucinous, …
Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K, Hefler LA, Heinze G, Paseka V, Grimm C, Tempfer CB. Hefler-Frischmuth K, et al. Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):65-8. doi: 10.1016/j.ejogrb.2009.06.010. Epub 2009 Jul 19. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19619929
Serum C-reactive protein (CRP) is a widely used biomarker of inflammation and has been previously shown to be a promising biomarker in patients with ovarian cancer. STUDY DESIGN: In a retrospective single-center study, we evaluated serum CRP in 576 patients with benign …
Serum C-reactive protein (CRP) is a widely used biomarker of inflammation and has been previously shown to be a promising biomarker in patie …
29 results